353 related articles for article (PubMed ID: 26603743)
1. Association between low-dose acetylsalicylic acid reinitiation and the risk of myocardial infarction or coronary heart disease death.
Sáez ME; González-Pérez A; Johansson S; Himmelmann A; García Rodríguez LA
Eur J Prev Cardiol; 2016 Jul; 23(10):1029-36. PubMed ID: 26603743
[TBL] [Abstract][Full Text] [Related]
2. Effect of baseline gastrointestinal risk and use of proton pump inhibitors on frequency of discontinuation of aspirin for secondary cardiovascular prevention in United kingdom primary care.
Martín Merino E; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiol; 2013 Oct; 112(8):1075-82. PubMed ID: 23831164
[TBL] [Abstract][Full Text] [Related]
3. Use of proton pump inhibitors and the risk of coronary events in new users of low-dose acetylsalicylic acid in UK primary care.
García Rodríguez LA; Johansson S; Nagy P; Cea Soriano L
Thromb Haemost; 2014 Jan; 111(1):131-9. PubMed ID: 24153412
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation of low dose aspirin and risk of myocardial infarction: case-control study in UK primary care.
Rodríguez LA; Cea-Soriano L; Martín-Merino E; Johansson S
BMJ; 2011 Jul; 343():d4094. PubMed ID: 21771831
[TBL] [Abstract][Full Text] [Related]
5. Represcription of low-dose acetylsalicylic acid after discontinuation in patients receiving treatment for secondary cardiovascular disease prevention in the UK.
Martín-Merino E; Johansson S; Nagy P; García Rodríguez LA
Am J Cardiovasc Drugs; 2014 Aug; 14(4):319-26. PubMed ID: 25027353
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular and upper gastrointestinal bleeding consequences of low-dose acetylsalicylic acid discontinuation.
Cea Soriano L; Bueno H; Lanas A; García Rodríguez LA
Thromb Haemost; 2013 Dec; 110(6):1298-304. PubMed ID: 24008261
[TBL] [Abstract][Full Text] [Related]
7. Mortality in patients who discontinue low-dose acetylsalicylic acid therapy after upper gastrointestinal bleeding.
González-Pérez A; Sáez ME; Johansson S; Nagy P; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2017 Feb; 26(2):215-222. PubMed ID: 27921360
[TBL] [Abstract][Full Text] [Related]
8. Statin Discontinuation, Reinitiation, and Persistence Patterns Among Medicare Beneficiaries After Myocardial Infarction: A Cohort Study.
Booth JN; Colantonio LD; Chen L; Rosenson RS; Monda KL; Safford MM; Kilgore ML; Brown TM; Taylor B; Dent R; Muntner P; Levitan EB
Circ Cardiovasc Qual Outcomes; 2017 Oct; 10(10):. PubMed ID: 29021332
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Prognosis of High-risk Myocardial Infarction Patient Candidates to Extended Antiplatelet Therapy.
Marrugat J; Elosua R; Grau M; Sayols-Baixeras S; Dégano IR
Rev Esp Cardiol (Engl Ed); 2016 May; 69(5):480-7. PubMed ID: 27062680
[TBL] [Abstract][Full Text] [Related]
10. Prevention of Stroke with Ticagrelor in Patients with Prior Myocardial Infarction: Insights from PEGASUS-TIMI 54 (Prevention of Cardiovascular Events in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin-Thrombolysis in Myocardial Infarction 54).
Bonaca MP; Goto S; Bhatt DL; Steg PG; Storey RF; Cohen M; Goodrich E; Mauri L; Ophuis TO; Ruda M; Špinar J; Seung KB; Hu D; Dalby AJ; Jensen E; Held P; Morrow DA; Braunwald E; Sabatine MS
Circulation; 2016 Sep; 134(12):861-71. PubMed ID: 27576775
[TBL] [Abstract][Full Text] [Related]
11. Addition of cilostazol to aspirin therapy for secondary prevention of cardiovascular and cerebrovascular disease in patients undergoing percutaneous coronary intervention: A randomized, open-label trial.
Ueda H; Kido A; Matsuhisa S; Asawa K; Yoshida N; Tsujimoto M; Sasaki Y; Kuga Y; Yamasaki M; Ueda K; Shinohara S; Nishida Y
Am Heart J; 2016 Mar; 173():134-42. PubMed ID: 26920606
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of stroke after discontinuation of acetylsalicylic acid: a UK primary care study.
García Rodríguez LA; Cea Soriano L; Hill C; Johansson S
Neurology; 2011 Feb; 76(8):740-6. PubMed ID: 21270415
[TBL] [Abstract][Full Text] [Related]
13. Antiplatelet therapy for stable coronary artery disease in atrial fibrillation patients taking an oral anticoagulant: a nationwide cohort study.
Lamberts M; Gislason GH; Lip GY; Lassen JF; Olesen JB; Mikkelsen AP; Sørensen R; Køber L; Torp-Pedersen C; Hansen ML
Circulation; 2014 Apr; 129(15):1577-85. PubMed ID: 24470482
[TBL] [Abstract][Full Text] [Related]
14. Primary Prevention of Myocardial Infarction in Rheumatoid Arthritis Using Aspirin: A Case-crossover Study and a Propensity Score-matched Cohort Study.
Durán J; Peloquin C; Zhang Y; Felson DT
J Rheumatol; 2017 Apr; 44(4):418-424. PubMed ID: 28250138
[TBL] [Abstract][Full Text] [Related]
15. Predictors and time trends in clopidogrel and proton pump inhibitor coprescription with low-dose acetylsalicylic acid.
Cea Soriano L; Bueno H; Johansson S; García Rodríguez LA
Pharmacoepidemiol Drug Saf; 2012 May; 21(5):463-9. PubMed ID: 22298501
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
[TBL] [Abstract][Full Text] [Related]
17. Incident Type 2 Myocardial Infarction in a Cohort of Patients Undergoing Coronary or Peripheral Arterial Angiography.
Gaggin HK; Liu Y; Lyass A; van Kimmenade RR; Motiwala SR; Kelly NP; Mallick A; Gandhi PU; Ibrahim NE; Simon ML; Bhardwaj A; Belcher AM; Harisiades JE; Massaro JM; D'Agostino RB; Januzzi JL
Circulation; 2017 Jan; 135(2):116-127. PubMed ID: 27881568
[TBL] [Abstract][Full Text] [Related]
18. Acetylsalicylic acid desensitization in patients with coronary artery disease: A comprehensive overview of currently available protocols.
Verdoia M; Barbieri L; Schaffer A; Nardin M; Suryapranata H; De Luca G
Vascul Pharmacol; 2016 May; 80():43-9. PubMed ID: 26456910
[TBL] [Abstract][Full Text] [Related]
19. Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding?
Gielen CL; Bruggemans EF; Stijnen T; Eikenboom J; Tavilla G; Brand A; Klautz RJ
Eur J Cardiothorac Surg; 2015 Oct; 48(4):e64-70. PubMed ID: 26248820
[TBL] [Abstract][Full Text] [Related]
20. Patterns of Antiplatelet Therapy in Patients Who Have Experienced an Acute Coronary Event: A Descriptive Study in UK Primary Care.
Sáez ME; González-Pérez A; Johansson S; Nagy P; Rodríguez LA
J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):378-86. PubMed ID: 25501499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
